Today in trading, Medicenna Therapeutics Corp shares opened at $2.25 and closed at $2.32. It traded at a low of $2.19 to a high of $2.41.

The price boosted 0.43% from the previous day's close of $2.31.

During the day across North America, the TSX Composite closed -1.35% at 21714.54, the S&P 500 closed 0.32% at 5116.17, the Dow Jones Industrial Average closed 0.38% at 38386.09 and the Nasdaq Composite closed 0.35% at 15983.08.

Medicenna Therapeutics Corp has listed on the Toronto Stock Exchange (TSX) under the ticker MDNA.

A total of 113,465 shares was traded during the last trading day, with total trades of 280. On average, Medicenna Therapeutics Corp has traded 335,504 shares in the last five days and 136,812 year-to-date.

The TSX market on the whole today saw 1,288 price advancers against 3,926 declines and 104 unchanged.

During the prior 52 weeks, MDNA.TO has traded as high as $2.68 (April 29,2024) and low as $0.22 (November 01,2023). Moreover, the shares have risen 157.78% in the last year, while they have risen 452.38% this year.

Following today's trading, Medicenna Therapeutics Corp has a market capitalization of $160.86 million on a float of 69,637 shares outstanding. Its annual EPS is $-0.23.

Medicenna Therapeutics Corp is a TSX Biotechnology company headquartered in Toronto, CAN.

Medicenna Therapeutics Corp's average recommendation is "Strong Buy" based on 2.00 analysts according to Zacks. From those 2 analysts, 2 have buy ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..